Stem cell therapy costs $5,000 to $50,000 per treatment, with the average landing around $10,000. That wide range depends on what condition you’re treating, where the cells come from, how many sessions you need, and whether you’re getting treated in the U.S. or abroad. Almost none of it is covered by insurance.
Cost by Condition
The price you’ll pay is shaped largely by what you’re treating. Orthopedic issues like knee osteoarthritis tend to sit at the lower end because they require smaller doses of cells delivered to a specific joint. Knee injections typically run $5,000 to $10,000. Back pain and shoulder treatments fall in a similar range, from $5,000 to $15,000. One patient at Mayo Clinic reported paying $4,650 total for stem cells plus a platelet-rich plasma injection for a joint issue.
Neurological and autoimmune conditions cost significantly more. Treatments for conditions like multiple sclerosis or severe inflammatory diseases start around $20,000 to $30,000 in the U.S. and can climb higher. Neuropathy treatments have historically ranged from $2,500 to $5,000, but the upper end has been creeping into the tens of thousands. Vision loss treatments start around $20,000. Cord blood cell treatments for autism, typically offered outside the U.S., generally run $20,000 and up.
The difference comes down to complexity. A single injection into a knee joint is a relatively straightforward procedure. Intravenous infusions for systemic conditions require more cells, more lab processing, and more clinical monitoring, all of which drive costs higher.
What Drives the Price Up
One of the biggest cost factors is where the stem cells come from. Treatments using your own tissue (drawn from bone marrow or fat) tend to cost $4,000 to $8,000 in the U.S. These require a harvest procedure, sometimes involving liposuction or a bone marrow aspiration, but the cells don’t need extensive lab work afterward.
Expanded cell products, where cells are grown and multiplied in a lab before being reinjected, cost considerably more. These treatments typically range from $15,000 to $45,000. The lab expansion process takes time, specialized equipment, and quality controls that all factor into the price. In 2025 polling of patients, the most commonly reported price bracket was $5,001 to $10,000, but the second most common answer was “more than $20,000,” reflecting how quickly costs escalate for more complex protocols.
Multiple Sessions Add Up
Some conditions respond to a single injection followed by a recovery period. Mild joint issues or initial diagnostic treatments often follow this approach. But more serious or chronic conditions typically require multiple injections spaced weeks or months apart, and some patients need ongoing injections every 6 to 12 months to maintain results.
Hair restoration illustrates how session counts multiply the total bill. A single session runs $6,000 to $8,000, but most patients need three to five sessions for meaningful results. That brings the total to $15,000 to $25,000 or more. The same math applies to other conditions: if you’re quoted $5,000 per session but need three rounds, your real cost is $15,000.
When evaluating a clinic’s quoted price, ask whether it covers the full treatment plan or just the first session. Also ask about pre-treatment costs like imaging, bloodwork, and consultations, which can add hundreds or thousands more.
U.S. vs. International Pricing
Medical tourism has become common for stem cell therapy, particularly to Mexico, where clinics in Tijuana and other border cities offer treatments at a fraction of U.S. prices. The savings can be dramatic:
- Knee arthritis: $5,000 to $10,000 in the U.S. vs. $1,500 to $3,100 in Mexico
- Multiple sclerosis: $20,000 to $30,000 in the U.S. vs. $7,000 to $8,500 in Mexico
- Psoriatic arthritis: $22,000 to $34,000 in the U.S. vs. $5,500 to $7,000 in Mexico
Lab work and imaging at international clinics often cost a third of U.S. prices, and some patients save up to 80% on those ancillary services. However, regulatory oversight varies significantly by country. The lower price may reflect lower operating costs, but it can also reflect fewer safety requirements. Clinics abroad may offer treatments with cell types or protocols that wouldn’t be permitted in the U.S.
Insurance Almost Never Covers It
The vast majority of stem cell therapies are paid entirely out of pocket. Medicare and private insurers generally cover only FDA-approved stem cell transplants, which are limited mostly to blood cancers and certain bone marrow disorders. The regenerative treatments marketed for joints, neurological conditions, and anti-aging are not FDA-approved for those uses, and insurers treat them as experimental.
There is one partial exception: if you enroll in a qualifying clinical trial, Medicare will cover routine costs like office visits, lab tests, and related procedures. It still won’t cover the experimental treatment itself, but it reduces the total financial burden. Private insurers have similar policies, though coverage for clinical trial participation varies by plan.
Some clinics offer financing plans, spreading payments over 12 to 24 months. This doesn’t reduce the total cost, but it makes the upfront hit more manageable. If a clinic is offering stem cell therapy and billing it to your insurance for an unapproved indication, that’s a red flag worth investigating before proceeding.
Why Prices Keep Rising
Stem cell therapy costs have been trending upward. Polling data from The Niche, a stem cell research site run by a UC Davis professor, shows that the most common price patients reported in late 2025 was $5,001 to $10,000, but the next most common bracket was over $20,000. Several factors are pushing prices higher: growing demand, increasingly complex lab processing for expanded cell products, and the costs clinics face to maintain some level of regulatory compliance. The lack of insurance coverage also removes the price pressure that exists in other areas of medicine, where insurers negotiate rates down. Without that check, clinics set their own prices based largely on what the market will bear.